Evidence map›Paper›PMID 34054802›Full record

ArticleFrontiers in immunology2021

Oxygen-Mediated Suppression of CD8+ T Cell Proliferation by Macrophages: Role of Pharmacological Inhibitors of HIF Degradation.

Milos Gojkovic, Pedro P Cunha, Gabriella S Darmasaputra, Laura Barbieri, Helene Rundqvist, Pedro Veliça, Randall S Johnson

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. The hypoxic microenvironment ofFrontiers in immunology · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Roxadustat: Do we know all the answers?Biomolecules & biomedicine · 2023
    Review
  8. Article
  9. Reoxygenation Modulates the Adverse Effects of Hypoxia on Wound Repair.International journal of molecular sciences · 2022
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Milos GojkovicDepartment of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
Pedro P CunhaDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Gabriella S DarmasaputraDepartment of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
Laura BarbieriDepartment of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
Helene RundqvistDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Pedro VeliçaDepartment of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
Randall S JohnsonDepartment of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
Karolinska Institutet · SE

Funding

Wellcome Trust
6 · The paper itself

Abstract

Myeloid cell interactions with cells of the adaptive immune system are an essential aspect of immunity. A key aspect of that interrelationship is its modulation by the microenvironment. Oxygen is known to influence myelosuppression of T cell activation in part

Indexed as

Adaptive ImmunityAnimalsCD8-Positive T-LymphocytesCell HypoxiaCell Line, TumorCell ProliferationCoculture TechniquesGlycineHumansHypoxia-Inducible Factor 1, alpha SubunitIsoquinolinesMacrophagesMiceMice, TransgenicOxygenVon Hippel-Lindau Tumor Suppressor ProteinGlycineHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitIsoquinolinesOxygenroxadustatVon Hippel-Lindau Tumor Suppressor ProteinHIFhypoxiaimmunosuppressionmyeloid cellsNitric oxideProlyl hydroxylase inhibitorsvon Hippel-Lindau.

Identifiers

PMID34054802
PMCPMC8153186
OpenAlexW3161535269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.